NIK-247 induces long-term potentiation of synaptic transmission in the CA1 region of rat hippocampal slices through M2 muscarinic receptors

General Pharmacology

Volumn 31, Issue 2, 1998, Pages 297-300

  Kojima, Jun ^a   Onodera, Kenji ^b  

^a Nikken Chemicals Co Ltd   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Atropine; Carbachol; Hippocampus; Longterm potentiation (LTP); McN A 343; NIK 247; Physostigmine; Pirenzepine; Tacrine

Indexed keywords

[4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM; AMIRIDINE; ATROPINE; CARBACHOL; PHYSOSTIGMINE; PIRENZEPINE; TACRINE;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CHOLINERGIC SYNAPSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; HIPPOCAMPUS; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

(4-(M-CHLOROPHENYLCARBAMOYLOXY)-2-BUTYNYL)TRIMETHYLAMMONIUM CHLORIDE; AMINOQUINOLINES; ANIMALS; CARBACHOL; CHOLINESTERASE INHIBITORS; ELECTRIC STIMULATION; EVOKED POTENTIALS; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; PHYSOSTIGMINE; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; SYNAPTIC TRANSMISSION; TACRINE;

EID: 0031834152     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(97)00436-9     Document Type: Article

References (36)

1. Aniksztejn L. and Ben-Ari Y. (1991) Novel form of long-term potentiation produced by a K+ channel blocker in the hippocampus. Nature 349, 67-69.
2. Auerbach J. M. and Segal M. (1994) A novel cholinergic induction of long-term potentiation in rat hippocampus. J. Neurophysiol. 72, 2034-2040.
3. Barnes C. A. (1988) Spatial learning and memory processes: the search for their neurobiological mechanism in the rat. TINS 11, 163-169.
4. Bartus R. T., Dean R. L. III, Beer B. and Lippa A. S. (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217, 408-417.
5. Bliss T. V. P. and Collingridge G. L. (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39.
6. Bliss T. V. P. and Lomo T. (1973) Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J. Physiol. 232, 331-356.
7. Blitzer R. D., Gil O. and Landau E. M. (1990) Cholinergic stimulation enhances long-term potentiation in the CA1 region of rat hippocampus. Neurosci. Lett. 119, 207-210.
8. Bonner T. I., Buckley N. J., Young A. C. and Brann M. R. (1987) Identification of a family of muscarinic acetylcholine receptor genes. Science 237, 527-532.
9. Bortolotto Z. and Collingridge G. L. (1993) Characterization of LTP induced by the activation of glutamate metabotropic receptors in area CA1 of the hippocampus. Neuropharmacobgy 32, 1-9.
10. Doyere V. and Laroche S. (1992) Linear relationship between the maintenance of hippocampal long-term potentiation and retention of an associative memory. Hippocampus 2, 39-48.
11. Drachman D. A. and Leavit J. (1974) Human memory and the cholinergic system. Arch. Neurol. 30, 113-121.
12. Elrod K. and Buccafusco J. J. (1988) An evaluation of the mechanism of scopolamine-induced impairment in two passive avoidance protocols. Pharmac. Biochem. Behav. 29, 15-21.
13. Hall J. M., Caulfield M. P., Watson S. P. and Guard S. (1993) Receptor subtypes or species homologues: relevance to drug discovery. TIPS 14, 376-383.
14. Hammer R., Berrie C. P., Birdsall N. J. M., Burgen A. V. V. and Hulme E. C. (1980) Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature 283, 90-92.
15. Ishihara K., Katsuki H., Sugimura M. and Satoh M. (1989) Idebenone and vinpocetine augment long-term potentiation in hippocampal slices in the guinea pig. Neuropharmacology 28, 569-573.
16. Ishii Y., Kojima J., Ikeda N. and Kawashima K. (1994) Effect of NIK-247 on basal concentrations of extracellular acetylcholine in the cerebral cortex of conscious, freely moving rats. Jpn. J. Pharmac. 66, 289-293.
17. Ito T., Miura Y. and Kadokawa T. (1988) Effects of physostigmine and scopolamine on long-term potentiation of hippocampal population spikes in rats. Can. J. Physiol. Pharmac. 66, 1010-1016.
18. Kojima J. and Onodera K. (1997) Effects of NIK-247 and tacrine (THA) on muscarinic receptors in rats. Gen. Pharmac. 30, 537-541.
19. Kojima J., Nakajima K., Ochiai M. and Nakayama K. (1997) Effect of NIK-247 on cholinesterase and scopolamine-induced amnesia. Methods Find. Exp. Clin. Pharmac. 19, 245-251.
20. Langmoen I. A. and Andersen P. (1981) The hippocampal slice in vitro. A description of the technique and some examples of the opportunities it offers. In Electrophysiology of Isolated Mammalian CNS Preparations (Edited by Kerkut G. A. and Wheal H. V.), pp. 51-106. Academic Press, London.
21. Morimoto K. and Goddard G. (1985) Effects of thyrotropine-releasing hormone on evoked responses and long-term potentiation in dentate gyrus of rat. Exp. Neurol. 90, 401-410.
22. Morris R. G., Anderson E., Lynch G. S. and Baudry M. (1986) Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 319, 774-776.
23. Nabeshima T., Yoshida S. and Kameyama T. (1988) Effects of the novel compound NIK-247 on impairment of passive avoidance response in mice. Eur. J. Pharmac. 154, 263-270.
24. Pavia J., Ceballos M. L. and Cuesta F. S. (1996) Muscarinic receptors in Alzheimer's disease. Methods Find. Exp. Clin. Pharmac. 18(Suppl. B), 71-75.
25. Perry E. K., Tomlinson B. E., Blessed G., Bergman K., Gibson P. H. and Perry R. H. (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med. J. 2, 1456-1459.
26. Sarvey J. M. (1988) Protein synthesis in long-term potentiation and norepinephrine-induced long-lasting potentiation in hippocampus. In Long-Term Potentiation: From Biophysics to Behaviour (Edited by Landfield P. W. and Deadwyler S. A.), pp. 329-354. Alan R. Liss, New York.
27. Schwartzkroin P. A (1981) To slice or not to slice. In Electrophysiology of Isolated Mammalian CNS Preparations (Edited by Kerkut G. A. and Wheal H. V.), pp. 15-50. Academic Press, London.
28. Sunderland T., Tariot P. N. and Newhouse P. A. (1988) Differential responsivity of mood, behavior, and cognition to cholinergic agents in elderly neuropsychiatrie populations. Brain Res. Rev. 13, 371-389.
29. Tanaka Y., Sakurai M. and Hayashi S. (1989) Effect of scopolamine and HP 029, a cholinesterase inhibitor, on long-term potentiation in hippocampal slices of the guinea pig. Neurosci. Lett. 98, 179-183.
30. Ueki A. and Miyoshi K. (1989) Effects of cholinergic drugs on learning impairment in ventral globus pallidus-lesioned rats. J. Neurol. Sci. 90, 1-21.
31. Williams J. H., Errington M. L., Lynch M. A. and Bliss T. V. P. (1989) Arachidonic acid induces a long-term activity-dependent enhancement of synaptic transmission in the hippocampus. Nature 341, 739-742.
32. Williams S. and Johnston D. (1988) Muscarinic depression of long-term potentiation in CA3 hippocampal neurons. Science 242, 84-87.
33. Williamson A. M. and Sarvey J. M. (1985) Effects of cholinesterase inhibitors on evoked responses in field CA1 of the rat hippocampus. J. Pharmac. Exp. Ther. 235, 448-455.
34. Yamamoto T., Ohno M., Kitajima I., Yatsugi S. and Ueki S. (1993) Ameliorative effects of the centrally active cholinesterase inhibitor, NIK-247, on impairment of working memory in rats. Physiol. Behav. 53, 5-10.
35. Yoshida S. and Suzuki N. (1993) Antiamnesic and cholinomimetic side-effects of the cholinesterase inhibitors, physostigmine, tacrine and NIK-247 in rats. Eur. J. Pharmac. 250, 117-124.
36. Yoshida S., Nabeshima T., Kinbara K. and Kameyama T. (1992) Effects of NIK-247 on CO-induced impairment of passive avoidance in mice. Eur. J. Pharmac. 214, 247-252.